Author

G. Narzisi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. A. Jungbluth· 1 shared A. Clemenceau· 1 shared A. Corvelo· 1 shared A. D. Jayaprakash· 1 shared C. M. Lovly· 1 shared D. Correa Pinto· 1 shared E. J. Jordan· 1 shared E. Venturini· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Jungbluth

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring

D. Correa Pinto, I. Canal Delgado, H. Yang, A. Clemenceau, A. Corvelo, G. Narzisi, R. Musunuri, J. Berger, L. Hendricks, K. Tokumura, N. Luo, H. Li, F. Oury, P. Ducy, V. K. Yadav, , G. Karsenty

This study shows maternal and embryonic osteocalcin work together to maintain homeostasis in offspring by affecting insulin secretion, glucose metabolism, and steroidogenesis.

bioRxiv · Aug 11, 2023 · PreprintPhysiology

YES1 amplification: a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

P.-D. Fan, G. Narzisi, A. D. Jayaprakash, E. Venturini, N. Robine, P. Smibert, S. Germer, H. A. Yu, E. J. Jordan, P. K. Paik, Y. Y. Janjigian, J. E. Chaft, L. Wang, A. A. Jungbluth, S. Middha, , M. Ladanyi

This study identifies YES1 amplification as a novel mechanism of resistance to EGFR inhibitors in lung cancer using transposon mutagenesis and clinical genomic analysis.

bioRxiv · Mar 17, 2018Cancer Biology